Biotech & Genomic Medicine▲
CROセクターがA株をリード、睿智医薬が20%ストップ高
7月15日、CROセクターがA株市場をリードし、セクター内の全銘柄が上昇した。睿智医薬は寄り付きで1.04%高と上昇した後、急速に買われ、最終的に20%のストップ高で引け、10.39元/株、上昇率19.98%となった。昭衍新薬、百花医薬もストップ高となり、万邦医薬、奥浦邁などは10%超の上昇を見せた。
← Back
![]()
ChemPartner PharmaTech Co Ltd
ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehensive chemical drug research and development and biological drug services for large and medium-sized pharmaceutical companies, biotechnology companies, and scientific research institutions. The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to ChemPartner PharmaTech Co.,Ltd. in September 2020. ChemPartner PharmaTech Co.,Ltd. was founded in 2000 and is headquartered in Guangzhou, China.
Country
Sector
Themes
Also in